Earnings Call · Q4 FY2021·2022-02-23

Q4 21EPS +27.97%·Rev n/aQ3 21EPS +20.92%·Rev n/aQ2 21EPS -3.00%·Rev n/aQ1 21EPS +14.39%·Rev n/a⚠ consensus missing

Fulgent Genetics, Inc. FLGT

Nicole Borsje — Investor Relations

Ming Hsieh — Chief Executive Officer

Brandon Perthuis — Chief Commercial Officer

Paul Kim — Chief Financial Officer

+2.2%1d on move date+0.7% vs SPY3d+3.6%5d−2.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FLGT calls or request research access.

More FLGT calls Browse calls Request research access